These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21276239)

  • 1. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
    Lengerke C; Fehm T; Kurth R; Neubauer H; Scheble V; Müller F; Schneider F; Petersen K; Wallwiener D; Kanz L; Fend F; Perner S; Bareiss PM; Staebler A
    BMC Cancer; 2011 Jan; 11():42. PubMed ID: 21276239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.
    Huang YH; Luo MH; Ni YB; Tsang JY; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
    Histopathology; 2014 Mar; 64(4):494-503. PubMed ID: 24382260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
    Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
    Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
    Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
    PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
    Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
    du Puy L; Lopes SM; Haagsman HP; Roelen BA
    Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients.
    Tulsyan S; Agarwal G; Lal P; Mittal B
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1065-78. PubMed ID: 25223935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
    Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
    PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sox2 is essential for formation of trophectoderm in the preimplantation embryo.
    Keramari M; Razavi J; Ingman KA; Patsch C; Edenhofer F; Ward CM; Kimber SJ
    PLoS One; 2010 Nov; 5(11):e13952. PubMed ID: 21103067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Luo W; Li S; Peng B; Ye Y; Deng X; Yao K
    PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 13. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
    Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
    Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
    Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NANOG Plays a Hierarchical Role in the Transcription Network Regulating the Pluripotency and Plasticity of Adipose Tissue-Derived Stem Cells.
    Pitrone M; Pizzolanti G; Tomasello L; Coppola A; Morini L; Pantuso G; Ficarella R; Guarnotta V; Perrini S; Giorgino F; Giordano C
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of ID4 and its association with TP53 mutation, SOX2, SOX4 and OCT-4 expression levels.
    Galatro TF; Uno M; Oba-Shinjo SM; Almeida AN; Teixeira MJ; Rosemberg S; Marie SK
    PLoS One; 2013; 8(4):e61605. PubMed ID: 23613880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic implications of EpCAM and Sox2 expression in breast cancer.
    Abd El-Maqsoud NM; Abd El-Rehim DM
    Clin Breast Cancer; 2014 Feb; 14(1):e1-9. PubMed ID: 24201161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.
    Bae KM; Su Z; Frye C; McClellan S; Allan RW; Andrejewski JT; Kelley V; Jorgensen M; Steindler DA; Vieweg J; Siemann DW
    J Urol; 2010 May; 183(5):2045-53. PubMed ID: 20303530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox2 gene amplification significantly impacts overall survival in serous epithelial ovarian cancer.
    Belotte J; Fletcher NM; Alexis M; Morris RT; Munkarah AR; Diamond MP; Saed GM
    Reprod Sci; 2015 Jan; 22(1):38-46. PubMed ID: 25038052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.